文献速递乳腺MR

乳腺癌新辅助化疗后MRI非肿瘤乳腺组织环状强化:发生率和临床意义

Ring Enhancement in Non-Neoplastic Breast Tissue on MRI During Neoadjuvant Chemotherapy for Breast Cancer: Incidence and Clinical Implications.
PubMed 文献 · Acad Radiol · 2023-04-10

该回顾性研究纳入811例接受新辅助化疗的乳腺癌患者,发现5.8%在化疗后MRI上出现非肿瘤乳腺组织的新发环状强化。高背景实质强化(BPE)是独立相关因素(OR=2.08),HER2阳性可能增强此关联,该征象多可自行消失,认识它有助于避免不必要活检。

要点

  • 新辅助化疗后MRI上非肿瘤乳腺组织新发环状强化发生率为5.8%,多为短暂性。
  • HER2阳性癌症可能增强环状强化与高BPE的关联,避免误判为转移或新发病灶。

关键影像表现/征象

  • 化疗后MRI上非肿瘤乳腺组织出现新发环状强化,多数在后续MRI扫描中消失。
  • 环状强化与绝经前状态、年轻年龄、高乳腺X线密度及基线MRI高背景实质强化(BPE)相关。

诊断标准与关键数值

  • 在高BPE患者中,HER2阳性癌症与环状强化的关联OR=5.51,对比OR=2.54。

临床应用与阅片要点

  • 阅片时注意化疗后MRI新发环状强化多位于非肿瘤乳腺组织,常为短暂性,避免误诊为转移或新发肿瘤。
  • 对高BPE或HER2阳性患者,出现环状强化时应结合临床,避免不必要的活检。

局限性

  • 回顾性单中心研究,可能存在选择偏倚。
  • 环状强化的病理证实信息未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aimed to describe new lesions called ring enhancement in non-neoplastic breast tissue on breast magnetic resonance imaging (MRI) after neoadjuvant chemotherapy (NAC) in breast cancer patients, and to investigate the factors influencing their occurrence.

MATERIALS AND METHODS: We retrospectively reviewed 811 consecutive patients (mean age; 50.0 [range, 24-81] years) with breast cancer who had undergone NAC between January 2020 and December 2021, identifying cases with new ring enhancement on post-NAC MRI. We analyzed the MRI findings and identified factors that were potentially associated with ring enhancement through statistical analyses using the chi-square test, univariate and multivariate logistic regression analysis.

RESULTS: Forty-seven (5.8%) patients developed new ring enhancement on post-NAC MRI. The variables associated with ring enhancement were premenopausal status (p = 0.0007), younger age (p = 0.0011), high mammographic density (p = 0.0076), and high background parenchymal enhancement (BPE) on baseline MRI (p = 0.0001). Among these, high BPE was independently associated with the occurrence of ring enhancement (p = 0.0294, OR = 2.08; CI: 1.08-4.03). In a subset of high BPE patients, an association between HER2-positive cancers and ring enhancement was observed (odds ratio = 5.51 vs. 2.54). New lesion development exhibited no association with any specific NAC drug (p = 0.1676-0.7583 per drug).

CONCLUSION: Ring enhancement often occurs on post-NAC MRI and mostly disappears on subsequent MRI scans. High BPE on MRI was associated with this finding and HER2-positive cancers potentiated it. Knowledge of this finding can prevent unnecessary biopsies.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Oh, Han, Ko, et al. Ring Enhancement in Non-Neoplastic Breast Tissue on MRI During Neoadjuvant Chemotherapy for Breast Cancer: Incidence and Clinical Implications. Acad Radiol. 2023. PMID: 37045651. doi:10.1016/j.acra.2023.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。